CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 16,248	$ 6,829	$ 31,966	$ 13,052
General and administrative	7,334	3,081	13,767	5,251
Total operating expenses	23,582	9,910	45,733	18,303
Loss from operations	(23,582)	(9,910)	(45,733)	(18,303)
Other income:
Interest and other income, net	403	9	883	22
Total other income, net	403	9	883	22
Net loss	$ (23,179)	$ (9,901)	$ (44,850)	$ (18,281)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.74)	$ (7.56)	$ (1.43)	$ (14.16)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.74)	$ (7.56)	$ (1.43)	$ (14.16)
Weighted-average common shares outstanding, basic (in shares)	31,275,306	1,309,535	31,261,189	1,290,690
Weighted-average common shares outstanding, diluted (in shares)	31,275,306	1,309,535	31,261,189	1,290,690
Other comprehensive loss:
Unrealized loss on marketable securities	$ (730)	$ 0	$ (2,265)	$ 0
Total other comprehensive loss	(730)	0	(2,265)	0
Total comprehensive loss	$ (23,909)	$ (9,901)	$ (47,115)	$ (18,281)